Follow
Ahmed S Alshrari
Ahmed S Alshrari
Northern border university
Verified email at nbu.edu.sa
Title
Cited by
Cited by
Year
Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19
M Imran, M Kumar Arora, SMB Asdaq, SA Khan, SI Alaqel, ...
Molecules 26 (19), 5795, 2021
1852021
Cell culture, technology: enhancing the culture of diagnosing human diseases
SA Hudu, AS Alshrari, A Syahida, Z Sekawi
Journal of clinical and diagnostic research: JCDR 10 (3), DE01, 2016
952016
Innovations and development of COVID-19 vaccines: A patent review
AS Alshrari, SA Hudu, M Imran, SMB Asdaq, AM Ali, SI Rabbani
Journal of infection and public health 15 (1), 123-131, 2022
452022
High prevalence of qacA/B carriage among clinical isolates of meticillin-resistant Staphylococcus aureus in Malaysia
MN Shamsudin, MA Alreshidi, RA Hamat, AS Alshrari, SS Atshan, ...
Journal of Hospital Infection 81 (3), 206-208, 2012
452012
Synthetic molecules as DprE1 inhibitors: A patent review
M Imran, A AS, HK Thabet, Abida, M Afroz Bakht
Expert Opinion on Therapeutic Patents 31 (8), 759-772, 2021
362021
Innovations and patent trends in the development of USFDA approved protein kinase inhibitors in the last two decades
M Imran, SMB Asdaq, SA Khan, D Unnikrishnan Meenakshi, AS Alamri, ...
Pharmaceuticals 14 (8), 710, 2021
322021
Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review
M Imran, AS Alshrari, SMB Asdaq
Journal of Infection and Public Health 14 (8), 1075-1086, 2021
302021
Antibody and immune memory persistence post infant hepatitis B vaccination
SA Hudu, YA Malik, MT Niazlin, NS Harmal, A Adnan, AS Alshrari, ...
Patient preference and adherence, 981-986, 2013
302013
Knowledge, attitude and practices of healthcare professionals of riyadh, saudi arabia towards covid-19: a cross-sectional study
SMB Asdaq, AS Alshrari, M Imran, N Sreeharsha, R Sultana
Saudi Journal of Biological Sciences 28 (9), 5275-5282, 2021
292021
Highly dynamic transient colonization by Staphylococcus aureus in healthy Malaysian students
N VasanthaKumari, ASD Alshrari, EG Rad, HG Moghaddam, ...
Journal of medical microbiology 58 (Pt 11), 1531-1532, 2009
262009
Genetic variation among methicillin-resistant Staphylococcus aureus isolates from cancer patients in Saudi Arabia
MA Alreshidi, AA Alsalamah, RA Hamat, V Neela, AS Alshrari, SS Atshan, ...
European journal of clinical microbiology & infectious diseases 32, 755-761, 2013
252013
Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia
SA Hudu, NS Harmal, MI Saeed, AS Alshrari, YA Malik, MT Niazlin, ...
African health sciences 16 (3), 677-683, 2016
242016
Patterns of human respiratory viruses and lack of MERS‐coronavirus in patients with acute upper respiratory tract infections in southwestern province of Saudi Arabia
AA Abdulhaq, VK Basode, AM Hashem, AS Alshrari, NA Badroon, ...
Advances in Virology 2017 (1), 4247853, 2017
212017
Mucormycosis medications: a patent review
M Imran, A AS, M Tauseef, SA Khan, SA Hudu, Abida
Expert Opinion on Therapeutic Patents 31 (11), 1059-1074, 2021
182021
The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects
AS Alshrari, SA Hudu, F Elmigdadi, M Imran
Biomedicines 11 (2), 426, 2023
122023
Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: A patent review from 1998 to 2021
M Imran, SA Khan, Abida, AS Alshrari, MM Eltahir Mudawi, ...
Expert Opinion on Therapeutic Patents 32 (5), 591-604, 2022
122022
Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees
SA Hudu, NS Harmal, MI Saeed, AS Alshrari, YA Malik, MT Niazlin, ...
European Journal of Clinical Microbiology & Infectious Diseases 34, 1349-1359, 2015
122015
Isolated hepatitis B core antibody positive among vaccinated cohort in Malaysia
SA Hudu, YA Malik, MT Niazlin, NS Harmal, AS Alshrari, Z Sekawi
Annals of Saudi medicine 33 (6), 591-594, 2013
92013
VP37 protein inhibitors for mpox treatment: Highlights on recent advances, patent literature, and future directions
SA Hudu, AS Alshrari, A Al Qtaitat, M Imran
Biomedicines 11 (4), 1106, 2023
72023
Bioinformatics analysis of rhinovirus capsid proteins VP1-4 sequences for cross-serotype vaccine development
AS Alshrari, SA Hudu, SMB Asdaq, AM Ali, CV Kin, AR Omar, CP Pei, ...
Journal of infection and public health 14 (11), 1603-1611, 2021
62021
The system can't perform the operation now. Try again later.
Articles 1–20